Journal Article
S. K. Samal, Pastey, M., McPhillips, T. H., and Mohanty, S. B.,
“Bovine respiratory syncytial virus nucleocapsid protein expressed in insect cells specifically interacts with the phosphoprotein and the M2 protein.”,
Virology, vol. 193, no. 1, pp. 470-3, 1993.
S. Mohapatra, Park, S. J., Boyapalle, S., Pastey, M., Graham, B. S., and Blanck, G.,
“Human respiratory syncytial virus reduces the number of cells in S-phase and increases GADD153 expression in HEp-2 cells.”,
Acta virologica, vol. 53, no. 3, pp. 207-11, 2009.
E. C. McKenzie, Lupfer, C., Banse, H., Hinchcliff, K., Love, S., Nelson, S., Davis, M., Payton, M., and Pastey, M.,
“Hypogammaglobulinemia in racing Alaskan sled dogs.”,
Journal of veterinary internal medicine / American College of Veterinary Internal Medicine, vol. 24, no. 1, pp. 179-84, 2010.
C. Lupfer, Besnouin, D., Tepper, S. E., Maselko, M., Patton, K. M., and Pastey, M.,
“Increased Survivorship and Altered Cytokine Profile from Treatment of Influenza A H1N1-Infected Mice with Ekybion: A Drug Complex of Natural Extracts and Inorganic Compounds.”,
Evidence-based complementary and alternative medicine : eCAM, vol. 2011, p. 192079, 2011.
C. Lupfer, Stein, D. A., Mourich, D. V., Tepper, S. E., Iversen, P. L., and Pastey, M.,
“Inhibition of influenza A H3N8 virus infections in mice by morpholino oligomers.”,
Archives of virology, vol. 153, no. 5, pp. 929-37, 2008.
Q. Ge, Pastey, M., Kobasa, D., Puthavathana, P., Lupfer, C., Bestwick, R. K., Iversen, P. L., Chen, J., and Stein, D. A.,
“Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers.”,
Antimicrobial agents and chemotherapy, vol. 50, no. 11, pp. 3724-33, 2006.
K. A. Reese, Lupfer, C., Johnson, R. C., Mitev, G. M., Mullen, V. M., Geller, B. L., and Pastey, M.,
“A Novel Lactococcal Vaccine Expressing a Peptide from the M2 Antigen of H5N2 Highly Pathogenic Avian Influenza A Virus Prolongs Survival of Vaccinated Chickens.”,
Veterinary medicine international, vol. 2013, p. 316926, 2013.
S. K. Samal, Pastey, M., McPhillips, T., Carmel, D. K., and Mohanty, S. B.,
“Reliable confirmation of antibodies to bovine respiratory syncytial virus (BRSV) by enzyme-linked immunosorbent assay using BRSV nucleocapsid protein expressed in insect cells.”,
Journal of clinical microbiology, vol. 31, no. 12, pp. 3147-52, 1993.
M. Pastey, Crowe, J. E., and Graham, B. S.,
“RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and facilitates virus-induced syncytium formation.”,
Journal of virology, vol. 73, no. 9, pp. 7262-70, 1999.
T. L. Gower, Pastey, M., Peeples, M. E., Collins, P. L., McCurdy, L. H., Hart, T. K., Guth, A., Johnson, T. R., and Graham, B. S.,
“RhoA signaling is required for respiratory syncytial virus-induced syncytium formation and filamentous virion morphology.”,
Journal of virology, vol. 79, no. 9, pp. 5326-36, 2005.
M. Maselko, Ward, C., and Pastey, M.,
“A RhoA-derived peptide inhibits human immunodeficiency virus-1 entry in vitro.”,
Current HIV research, vol. 9, no. 1, pp. 1-5, 2011.
M. Pastey, Gower, T. L., Spearman, P. W., Crowe, J. E., and Graham, B. S.,
“A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3.”,
Nature medicine, vol. 6, no. 1, pp. 35-40, 2000.
C. Lupfer, Patton, K. M., and Pastey, M.,
“Treatment of human respiratory syncytial virus infected Balb/C mice with the proteasome inhibitor bortezomib (Velcade, PS-341) results in increased inflammation and mortality.”,
Toxicology, vol. 268, no. 1-2, pp. 25-30, 2010.